Berlin-based aap Implantate AG moves to bolster its balance sheet through a dual-track capital increase, combining a rights offering with a planned contribution in kind.
aap Implantate AG has initiated a capital increase utilizing authorized capital with subscription rights granted to existing shareholders. Furthermore, the company has announced an intended capital increase in kind, which collectively signals a significant restructuring of the company's equity base that may lead to dilution for current investors.
The company announced a capital increase with subscription rights from authorized capital and an intended capital increase in kind.
Yes, the announcement was published as insider information pursuant to Article 17 of Regulation (EU) No. 596/2014.
aap Implantate AG has initiated a capital increase utilizing authorized capital with subscription rights for existing shareholders. The company also disclosed plans for a subsequent capital increase in kind, signaling a shift in its equity structure and potential dilution for current investors.
The company is executing a capital increase with subscription rights and preparing for a capital increase in kind to adjust its financial structure.